Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$363M |
| 2 |
Nike
NKE
|
+$289M |
| 3 |
Home Depot
HD
|
+$271M |
| 4 |
Mastercard
MA
|
+$180M |
| 5 |
Amazon
AMZN
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$226M |
| 2 |
Coca-Cola
KO
|
+$225M |
| 3 |
Meta Platforms (Facebook)
META
|
+$205M |
| 4 |
Johnson & Johnson
JNJ
|
+$199M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 11.84% |
| 4 | Consumer Discretionary | 9.23% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONVI
2651
DELISTED
Onvia, Inc.
ONVI
| $740K | ﹤0.01% |
191,300
+300
| +0.2% | +$1.1K |
|
2652
Wave Life Sciences
WVE
$1.02B
| $739K | ﹤0.01% |
+35,700
| New | +$556K |
|
2653
Helmerich & Payne
HP
$4.29B
| $738K | ﹤0.01% |
11,000
-141,900
| -93% | -$8.77M |
|
|
PQ
2654
DELISTED
Petroquest Energy Inc Wd
PQ
| $734K | ﹤0.01% |
+220,325
| New | +$649K |
|
|
MAGN
2655
Magnera Corp
MAGN
$443M
| $732K | ﹤0.01% |
2,877
-1,123
| -28% | -$302K |
|
|
MATN
2656
DELISTED
Mateon Therapeutics, Inc.
MATN
| $732K | ﹤0.01% |
+1,045,800
| New | +$741K |
|
2657
Shinhan Financial Group
SHG
$34.6B
| $730K | ﹤0.01% |
+22,300
| New | +$765K |
|
2658
Upland Software
UPLD
$14.9M
| $730K | ﹤0.01% |
9,580
+3,233
| +51% | +$232K |
|
|
OSB
2659
DELISTED
Norbord Inc.
OSB
| $728K | ﹤0.01% |
+37,300
| New | +$772K |
|
2660
Landmark Bancorp
LARK
$197M
| $725K | ﹤0.01% |
46,598
+2,118
| +5% | +$33K |
|
2661
Data I/O
DAIO
$30.8M
| $722K | ﹤0.01% |
307,200
+5,300
| +2% | +$12.8K |
|
2662
Radiant Logistics
RLGT
$400M
| $721K | ﹤0.01% |
240,360
-87,029
| -27% | -$306K |
|
|
ACW
2663
DELISTED
Accuride Corp
ACW
| $719K | ﹤0.01% |
580,200
+45,200
| +8% | +$68.1K |
|
2664
Coffee Holding Co
JVA
$20.2M
| $717K | ﹤0.01% |
126,900
+34,100
| +37% | +$146K |
|
2665
PTC Therapeutics
PTCT
$6.01B
| $715K | ﹤0.01% |
101,900
-846,800
| -89% | -$6.21M |
|
2666
MIND Technology
MIND
$42.6M
| $714K | ﹤0.01% |
19,030
+7,890
| +71% | +$291K |
|
|
AUTO
2667
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $712K | ﹤0.01% |
51,300
+15,800
| +45% | +$241K |
|
2668
BGSF Inc
BGSF
$57.6M
| $711K | ﹤0.01% |
+37,600
| New | +$577K |
|
|
COB
2669
DELISTED
CommunityOne Bancorp
COB
| $709K | ﹤0.01% |
56,100
+400
| +0.7% | +$5.27K |
|
|
FWDI
2670
Forward Industries Inc
FWDI
$305M
| $699K | ﹤0.01% |
59,240
+370
| +0.6% | +$4.77K |
|
|
ACER
2671
DELISTED
Acer Therapeutics Inc
ACER
| $698K | ﹤0.01% |
16,233
+2,007
| +14% | +$59.7K |
|
2672
Triumph Financial Inc
TFIN
$1.87B
| $694K | ﹤0.01% |
43,400
-1,600
| -4% | -$25.4K |
|
|
NRE
2673
DELISTED
NorthStar Realty Europe Corp.
NRE
| $694K | ﹤0.01% |
+75,000
| New | +$841K |
|
2674
Ameresco
AMRC
$1.47B
| $691K | ﹤0.01% |
158,200
+128,300
| +429% | +$583K |
|
|
CBD
2675
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $690K | ﹤0.01% |
+47,400
| New | +$624K |
|
Similar funds
Jim Simons's Q2 2016 Portfolio in Review
As of Q2 2016, Jim Simons held 3,774 positions worth $52.5B, down 0.13% from $52.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
Jim Simons withdrew a net $1.64B in Q2 2016, closing 474 positions and reducing 1,158 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Jim Simons opened a new position in Nike worth $280M.
- Jim Simons's largest Q2 2016 buy was Nike: 5,066,500 shares worth $280M.
- Jim Simons added most to CVS Health in Q2 2016, an estimated $363M increase.
- Jim Simons's biggest Q2 2016 reduction was PepsiCo, cutting an estimated $226M.
- Jim Simons fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 8% of its $52.5B portfolio in Q2 2016.
- Jim Simons opened 423 new positions and closed 474 in Q2 2016.
- Jim Simons's portfolio value fell 0.13% quarter-over-quarter to $52.5B.
Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.